Summary
The PRA Bioanalytical Laboratory has over 10 years of experience with transfer, development, validation, and bioanalysis of anti-drug antibody (ADA) assays in support of pre-clinical and clinical trials. Given the different types of biologics on the market and challenges of achieving appropriate sensitivity and drug tolerance for ADAs, PRA’s experienced scientists have the expertise to overcome and mitigate these challenges.
Register to download
Anti-drug antibody assays at PRA’s Laboratory for Drug Development
You may also be interested in:
Resource
qPCR at PRA’s Laboratories for Drug Development
We see new drug types being studied more and more, such as cell and gene therapies. For some of these drug types, qPCR is a valuable technology to…
Resource
Flow Cytometry at PRA’s Laboratories for Drug Development
PRA has 10+ years of experience performing flow cytometry in clinical trials, and we implemented a broad range of assay types to analyze sample types…
Fact Sheet
PRA’s Laboratory Solutions For Drug Development
At PRA Health Sciences, we recognize that the world of clinical development is complex and dynamic, and we’ve designed our laboratories for drug…